Figure 1.

Recruitment of participants and flow over 6-months. ^aTime constraints meant that 257 children received Silver fluoride therapies after the initial recruitment phase at but were either not present during the initial baseline recruitment phase or time-constraints did not facilitate inclusion. ^bSDF refer to Rivastar Silver Diammine Fluoride (38%). ^cKI refers to a clinical protocol where second step of Potassium Iodide is placed. ^dAgF refers to the experimental 38% Silver Fluoride solution with an Aqueous base.